United Therapeutics Corporation (UTHR) Insider Trading

Total insider buys:
  • $999,400.80
Total insider sells:
  • $773,721,457.77
Most recent insider trade:
  • Nov. 11, 2024
Most active insider trader:
  • Martine A Rothblatt
Trader NameDateTitleAmountPriceTypeTotal Value
April 13, 2017CEO1,258$122.12Sell$153,626.96
April 6, 2017CEO1,257$122.39Sell$153,844.23
March 30, 2017CEO1,230$134.56Sell$165,508.80
March 23, 2017CEO1,219$139.33Sell$169,843.27
March 22, 2017Director2,000$139.37Sell$278,740.00
March 16, 2017CEO1,218$140.16Sell$170,714.88
March 9, 2017CEO1,206$146.72Sell$176,944.32
March 2, 2017CEO1,203$148.49Sell$178,633.47
Feb. 23, 2017CEO1,208$145.16Sell$175,353.28
Feb. 16, 2017CEO1,173$167.92Sell$196,970.16
Jan. 12, 2017CEO1,214$142.37Sell$172,837.18
Jan. 12, 2017Director5,000$141.99Sell$709,950.00
Jan. 5, 2017CEO1,208$145.73Sell$176,041.84
Dec. 29, 2016CEO1,211$143.63Sell$173,935.93
Dec. 22, 2016CEO1,218$140.23Sell$170,800.14
Dec. 15, 2016CEO1,212$143.11Sell$173,449.32
Dec. 8, 2016CEO1,236$131.78Sell$162,880.08
Dec. 6, 2016Director5,000$133.37Sell$666,850.00
Dec. 1, 2016CEO1,246$126.86Sell$158,067.56
Nov. 25, 2016CEO1,233$132.81Sell$163,754.73
Nov. 17, 2016CEO1,232$132.94Sell$163,782.08
Nov. 10, 2016CEO1,240$129.82Sell$160,976.80
Nov. 10, 2016Director5,000$131.42Sell$657,100.00
Nov. 3, 2016CEO1,272$116.94Sell$148,747.68
Oct. 27, 2016CEO1,272$117.06Sell$148,900.32
Oct. 20, 2016CEO1,282$113.30Sell$145,250.60
Oct. 13, 2016CEO1,269$117.99Sell$149,729.31
Oct. 6, 2016CEO1,260$121.17Sell$152,674.20
Sept. 29, 2016CEO1,272$116.94Sell$148,747.68
Sept. 26, 2016Director1,291$125.57Sell$162,110.87
Sept. 22, 2016CEO1,249$125.87Sell$157,211.63
Sept. 15, 2016CEO1,258$122.34Sell$153,903.72
Sept. 8, 2016CEO1,254$123.44Sell$154,793.76
Sept. 1, 2016CEO1,257$122.81Sell$154,372.17
Sept. 1, 2016Director5,000$122.73Sell$613,650.00
Aug. 25, 2016CEO1,250$125.29Sell$156,612.50
Aug. 18, 2016CEO1,249$125.88Sell$157,224.12
Aug. 11, 2016CEO1,253$124.09Sell$155,484.77
Aug. 4, 2016CEO1,249$125.78Sell$157,099.22
July 28, 2016CEO1,271$117.05Sell$148,770.55
July 21, 2016CEO1,284$112.77Sell$144,796.68
July 14, 2016CEO1,292$110.05Sell$142,184.60
July 7, 2016CEO1,293$109.87Sell$142,061.91
June 30, 2016CEO1,308$105.10Sell$137,470.80
June 23, 2016CEO1,312$104.07Sell$136,539.84
June 16, 2016CEO1,308$105.18Sell$137,575.44
June 9, 2016CEO1,277$114.99Sell$146,842.23
June 8, 2016Director2,000$115.62Sell$231,240.00
June 2, 2016Director3,000$118.82Sell$356,460.00
June 2, 2016CEO1,261$120.79Sell$152,316.19
  • Insiders are both buying and selling United Therapeutics Corporation stock.

  • The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, John Maxim Ferrari, Raymond Dwek, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, James Edgemond, Nilda Mesa, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Michael Benkowitz, Ray Kurzweil, Paul A. Mahon, Louis Sullivan, R Paul Gray, Judy D. Olian, Tommy G. Thompson, DWEK RAYMOND, and MAHON PAUL A

  • The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.

  • Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.

  • Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.

  • The most recent insider trade for United Therapeutics Corporation was on Nov. 11, 2024.

  • The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.

  • The single biggest insider sell for United Therapeutics Corporation was from Michael Benkowitz with a total value of $8,084,500.00 on Aug. 7, 2024.